LB Pharmaceuticals Inc (LBRX)
NASDAQ · Manufacturing · Pharmaceutical preparations
LBRX price, last 12 months
Key stats
- Previous close
- $37.80
- Open
- $37.85
- Day range
- $36.99 – $38.57
- 52-week range
- $13.36 – $50.16
- Volume
- 336K
- Avg volume (20 days)
- 306.4K
- Market cap
- $1.2B
Performance
Technicals and fundamentals
About LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.2B